Ramir Luan Perin

4PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 20, 2023
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.

Adriana Zanoni Dotti, Daniela Oliveira Magro, Eduardo Garcia Vilela

|Feb 13, 2023
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.

Ramir Luan Perin, Daniela Oliveira Magro, Adriana Ribas Andrade

|Mar 23, 2021
Preoperative Anti-TNF Agents and Morbidity After Ileocolonic Resections in Crohn's Disease: Are Biologics the Only Ones to Blame?

Ramir Luan Perin, Natália Sousa Freitas Queiroz, Paulo Gustavo Kotze

|Oct 22, 2019
VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDY.

Ramir Luan Perin, Aderson Omar Mourão Cintra Damião, Cristina Flores

Pageof 1